Quality of life after long-term biochemical control of acromegaly.

Allison KimballLaura E DichtelKevin C J YuenWhitney W WoodmanseeMelanie S HainesLisa B NachtigallBrooke SwearingenPamela JonesNicholas A TritosJulie L SharplessUrsula B KaiserAnu GerweckKaren K Miller

Published in: Pituitary (2022)

A history of acromegaly and development of GHD, but not pharmacologic or radiotherapy, are detrimental to QoL, which remains poor over the long-term despite biochemical control.

Keyphrases

early stage
radiation therapy
locally advanced